Evidence map›Paper›PMID 21508125›Full record

Trial reportHaematologica2011

Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications.

Katherine R Calvo, Donald C Vinh, Irina Maric, Weixin Wang, Pierre Noel, Maryalice Stetler-Stevenson, Diane C Arthur, Mark Raffeld, Amalia Dutra, Evgenia Pak and 5 more

3 registry-linked trialsOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Haematologica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00018044 recruitingnot on this map

Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2001Enrolled1,000ConditionsMycobacterium InfectionsArmsClofazimine
NCT00923364 phase2completednot on this map

Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for Patients With GATA2 Mutations

TypeinterventionalSponsorNational Cancer Institute (NCI)Ran2009 to 2017Enrolled19ConditionsMDS, Immunodeficiency, GATA2ArmsCyclophosphamide (CTX, Cytoxan), Fludarabine(Fludara,Berlex Laboratories), Total Body Irradiation (TBI), Allogeneic Hematopoietic Stem Cell (HSC), Equine Anti-Thymocyte Globulin
NCT01212055 recruitingnot on this map

Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells From Patients With DOCK8 Deficiency, LAD-1, and GATA2 Deficiency

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2010Enrolled7ConditionsLAD-1, DOCK8, GATA2 Deficancy
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.Virchows Archiv : an international journal of pathology · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Katherine R CalvoHematology Section, Department of Laboratory Medicine, NIH Clinical Center, 10 Center Dr., Bethesda, MD 20892-1508, USA. calvok@mail.nih.gov
Donald C Vinh
Irina Maric
Weixin Wang
Pierre Noel
Maryalice Stetler-Stevenson
Diane C Arthur
Mark Raffeld
Amalia Dutra
Evgenia Pak
Kyungjae Myung
Amy P Hsu
Dennis D Hickstein
Stefania Pittaluga
Steven M Holland
Center for Cancer Research · USNational Institutes of Health Clinical Center · USNational Human Genome Research Institute · USNational Institute of Allergy and Infectious Diseases · USNational Cancer Institute · US

Funding

Molecular Diagnostics Core LaboratoryZICBC011079 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI XI, LIQIANG · 2009 to 2025
$33.8M
Flow Cytometric Analysis of Benign and Malignant TumorsZICSC009372 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI WANG, HAO-WEI · 2009 to 2025
$29.6M
Genes And Gene Products As ImmunoadjuvantsZIAAI000647 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOLLAND, STEVEN · 2009 to 2025
$22.6M
NHGRI/DIR Cytogenetics and Microscopy CoreZICHG200348 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI WINCOVITCH, STEPHEN · 2010 to 2025
$20.3M
Hematopoietic Stem Cell Transplant for Immunodeficiency with MDSZIABC010870 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HICKSTEIN, DENNIS · 2009 to 2025
$18.8M
Genome Instability in Cancer DevelopmentZIAHG012003 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MYUNG, KYUNGJAE · 2009 to 2015
$7.0M
Clinical Cancer CytogeneticsZIDBC010694 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ARTHUR, DIANE C · 2009 to 2016
$6.2M
Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic DiseasesZIACL090027 · CLC · CLINICAL CENTER · PI MARIC, IRINA · 2010 to 2025
$0k
The Role of microRNA in Hematologic MalignanciesZIACL090025 · CLC · CLINICAL CENTER · PI CALVO, KATHERINE · 2010 to 2025
$0k
6 · The paper itself

Abstract

A novel, genetic immunodeficiency syndrome has been recently described, herein termed "MonoMAC". It is characterized by severe circulating monocytopenia, NK- and B-lymphocytopenia, severe infections with M. avium complex (MAC), and risk of progression to myelodysplasia/acute myelogenous leukemia. Detailed bone marrow analyses performed on 18 patients further define this disorder. The majority of patients had hypocellular marrows with reticulin fibrosis and multilineage dysplasia affecting the myeloid (72%), erythroid (83%) and megakaryocytic (100%) lineages. Cytogenetic abnormalities were present in 10 of 17 (59%). Despite B-lymphocytopenia, plasma cells were present but were abnormal (e.g. CD56(+)) in nearly half of cases. Increased T-cell large granular lymphocyte populations were present in 28% of patients. Chromosomal breakage studies, cell cycle checkpoint functions, and sequencing of TERT and K-RAS genes revealed no abnormalities. MonoMAC appears to be a unique, inherited syndrome of bone marrow failure. We describe distinctive bone marrow features to help in its recognition and diagnosis. (Clinicaltrials.gov identifiers: NCT00018044, NCT00923364, NCT01212055).

Indexed as

AdolescentAdultAgedAged, 80 and overChildCytogenetic AnalysisDisease ProgressionFemaleGenomic InstabilityHumansImmunologic Deficiency SyndromesImmunophenotypingLeukemia, Myeloid, AcuteLeukopeniaLymphocytesMale

Identifiers

PMID21508125
PMCPMC3148917
OpenAlexW2153657294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.